期刊文献+

小剂量GP方案治疗老年非小细胞肺癌的临床研究

下载PDF
导出
摘要 目的:观察小剂量吉西他滨联合小剂量顺铂(GP)治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效。方法:50例老年非小细胞肺癌接受小剂量吉西他滨联合小剂量顺铂化疗,吉西他滨:300mg/m^2,静脉滴注30min,第1、8天;顺铂:20 mg/m^2,第1、2天,21天为1周期,4个周期后观察疗效和副作用。结果:总有效率为24%,临床收益率为56%,毒副作用较少,患者均可耐受。结论:小剂量化疗治疗老年NSCLC有一定的疗效,且毒副作用较小,增加肿瘤治疗的机会。
出处 《中国农村卫生》 2015年第5X期9-10,共2页
  • 相关文献

参考文献3

二级参考文献24

  • 1陈素琼,师卫华,袁葆琳,梁海田.NP方案治疗晚期非小细胞肺癌的疗效观察[J].现代肿瘤医学,2006,14(10):1225-1226. 被引量:1
  • 2Azzoli CG,Baker S Jr,Temin S,et al. American society of clinical oneology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer [ J ]. J Clin Oneol, 2009,27 (36) :6251 -6266.
  • 3Scagliotti GV,Parikh P,von Pawel J,et al. Phase Ul study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage NSCLC [ J ]. J Clin Oncol, 2008,26 ( 21 ) : 3543 - 3551.
  • 4Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or bearboplatin- paclitaxel in pulmonary aitenocarcinoma[ J]. N Engl J Med,2009, 361 (10) :947 -957.
  • 5Ciuleanu T, Brodowicz T, Zielinski C, et 81. Maintenance peme- trexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double- blind,phase 3 study[J].Lancet,2009,374(9699) :1432 -1440.
  • 6Chrischilles EA,Pendergast JF,Kahn KL,et al.Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer[J].J Clin Oncol,2010,28(4):620.
  • 7Pallis AG,Gridelli C,van Meerbeeck JP,et al.EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology(SIOG) exports' opinion for the treatment of non-small-cell lung cancer in an elderly population[J].Ann Oncol,2010,21 (4):692.
  • 8Ramalingam SS,Dahlberg SE,Langer CJ,et al.Outcomes for elderly,advanced-stage non-small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel:Analysis of eastern cooperative oncology group trial 4599[J].J Clin Oncol,2008,26 (1):60.
  • 9Sakakibara T,Inoue A,Sngawara S,et al.Randomized phase Ⅱ trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer[J].Ann Oncol,2010,21(4):75.
  • 10Firvida JL,Vazquez S,Grande C,et al.Oral vinorelbine (NVBO) and gemcitabine (GEM) in elderly patients with advanced non-small-cell lung cancer (NSCLC):A phase Ⅱ study conducted by the Gelieian Lung Cancer Group (GLCG)[J].J Clin Oncol,2008,26 (15S):19068.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部